Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | EVT801 |
Trade Name | |
Synonyms | EVT-801|EVT 801 |
Drug Descriptions |
EVT801 inhibits FLT4 (VEGFR3), potentially resulting in enhanced antitumor immune response, and inhibition of tumor angiogenesis and tumor development (Cancer Res 2019;79(13 Suppl):Abstract nr 4079; Cancer Res 2017;77(13 Suppl):Abstract nr 2634). |
DrugClasses | VEGFR3 Inhibitor 6 |
CAS Registry Number | NA |
NCIT ID | C185284 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
EVT801 | EVT801 | 0 | 1 |
EVT801 + unspecified PD-1 antibody | EVT801 unspecified PD-1 antibody | 0 | 0 |